RE: Fundamentals Roughtrader2,
We are on the Ad"Venture" exchange. I don't think anyone expects blue chip Fundamentals here. But perhaps we can get a drift as to what the Fundamental Game plan is. Here are some Exerps from the news.
"With the recent, significant announcements that the PreVu POC Test has been cleared for sale by Health Canada and has been CE-Marked for sale in the European Union, Management believes it is important to remind the market that an FDA clearance for the PreVu POC Test was in place at the time of our acquisition and was one of the key considerations in our decision to purchase PreVu," said Christopher J. Moreau, President and CEO of Miraculins. "PreVu's regulatory clearance in the U.S. is a valuable asset that we will soon be capitalizing on as we finalize our U.S. expansion strategy and begin to execute on our plans."
Currently, the Company is considering multiple distribution strategies and partners, including both user pay and reimbursement models. With regards to the latter, Miraculins has also launched a key, in-depth study designed to generate a comprehensive, reimbursement environmental assessment for its skin cholesterol technology, including a review of coding and valuation, as well as coverage assessments of applicable comparative technologies and clinical procedures.
Miraculins can begin to market the PreVu test in the U.S. after registering with the FDA as a device establishment, and after PreVu is listed as a device under Miraculins. This step is strictly administrative and is being timed to coincide with the finalization of the Company's U.S. sales and marketing launch strategy and the preparation of all related support materials and product labeling, including a web site being built exclusively for the U.S. marketplace. By registering and listing, Miraculins will be informing the FDA that commercial distribution has commenced. Miraculins has indicated it plans to register shortly and will update the market accordingly on its specific U.S. launch plans at that time.
So, the better questions are:
Does management have a reasonable game plan? Seems so.
What's going on now? Insiders are buying from the market and from 10 cent warrants injecting more cash into the company. Looks promising.
Will they need more cash? If so, the low float can get them more cash from a higher price point.
How long do we have to wait? 3 days to 3 months, who really knows. Very likely this very year would be a safe bet.
What's the potential return. from .13 cents. Well, EKG has done 10 bags just on FDA approval without even selling one product. I'm in EKG and we're waiting for just that. It went from .04 to over .40 on FDA approval alone. MDX has a similar success story but it's not a 10 begger yet. But the difference with MOM is that their FDA approval will coincide with actual products on the shelves. So we can speculate all we want but it's safe to say the return will be pretty good.
So I bought in and will be looking to accumulate a massive position.